A total synthesis of xestodecalactone A and proof of its absolute stereochemistry: Interesting observations on dienophilic control with 1,3-disubstituted nonequivalent allenes

Journal of the American Chemical Society

Volumn 128, Issue 43, 2006, Pages 14185-14191

  Yoshino, Toshiharu ^a   Ng, Fay ^a   Danishefsky, Samuel J ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSEMBLY; KETONES; STEREOCHEMISTRY; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

DIELS-ALDER STRATEGY; DIENOPHILIC CONTROL; RESORCYLINIC ACID; XESTODECALACTONE;

OLEFINS;

ALLENE DERIVATIVE; AROMATIC COMPOUND; LACTONE DERIVATIVE; RESOCYLINIC ACID; UNCLASSIFIED DRUG; XESTODECALACTONE A;

ARTICLE; CHEMICAL BOND; CHEMICAL REACTION; CHEMICAL STRUCTURE; CYCLOADDITION; DIELS ALDER REACTION; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SYNTHESIS;

ALKADIENES; CYCLIZATION; LACTONES; STEREOISOMERISM;

EID: 33750479505     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja064270e     Document Type: Article

References (72)

1. Omura, S., Ed. Macrolide Antibiotics: Chemistry. Biology, and Practice, 2nd ed.; Academic Press: San Diego, CA, 2002.
2. Betina, V. Mycotoxins. Chemical, Biology and Environmental Aspects; Elsevier: Amsterdam, 1989.
3. For structure and isolation: (a) Aldridge, D. C.; Gait, S.; Giles, D.; Turner, W. B. J. Chem. Soc. (C) 1971, 1623.
4. (b) Lee, K.-H.; Hayashi, N.; Okano, M.; Hall, I. H.; Wu, R.-Y.; McPhail, A. T. Phytochemistry 1982, 21, 1119.
5. For structure and isolation: (a) Stob, M.; Baldwin, R. S.; Tuite, J.; Andrews, F. N.; Gillette, K. G. Nature 1962, 196, 1318.
6. (b) Urry, W. H.; Wehrmeister, H. L.; Hodge, E. B.; Hidy, P. H. Tetrahedron Lett. 1966, 3109.
7. For structure and isolation: (a) Delmotte, P.; Delmotte-Plaquee, J. Nature 1953, 171, 344.
8. (b) Ayer, W. A.; Lee, S. P.; Tsunda, A.; Hiratsuka, Y. Can. J. Microbiol. 1980, 26, 766.
9. For structure and isolation: Isaka, M.; Suyarnsestakorn, C.; Tanticharoen, M.; Kongaseree, P.; Thebtaranonth, Y. J. Org. Chem. 2002, 67, 1561.
10. For structure and isolation: (a) Nair, M. S. R.; Carey, S. T. Tetrahedron Lett. 1980, 21, 2001.
11. (b) Nair, M. S. R.; Carey, S. T.; James, J. C. Tetrahedron 1981, 37, 2445.
12. (c) Agatsuma, T.; Takahashi, A.; Kabuto, C.; Nozoe, S. Chem. Pharm. Bull. 1993, 41, 373.
13. For selected references of other syntheses of lasiodiplodin: (a) Gerlach, H.; Thalmann, A. Helv. Chim. Acta 1977, 60, 2866.
14. (b) Takahashi, T.; Kasuga, K.; Tsuji, J. Tetrahedron Lett. 1978, 4917.
15. (c) Fink, M.; Gaier, H.; Gerlach, H. Helv. Chim. Acta 1982, 65, 2563.
16. (d) Braun, M.; Mahler, U.; Houben, S. Liebigs Ann. 1990, 513.
17. (e) Jones, G. B.; Huber, R. S. Synlett 1993, 367.
18. (f) Brachen, F.; Schulte, B. J. Chem. Soc., Perkin Trans. 1 1996, 2619.
19. (g) Furstner, A.; Thiel, O. R.; Kindler, N.; Bartkowska, B. J. Org. Chem. 2000, 65, 7990.
20. For selected references of syntheses of zearalenone: (h) Vlattas, I.; Harrison, I. T.; Tokes, L. Fried, J. H.; Cross, A. D. J. Org. Chem. 1968, 33, 4176.
21. Girotra, N. N.; Wendler, N. L. J. Org. Chem. 1969, 34, 3192.
22. (j) Corey, E. J.; Nicolaou, K. C. J. Am. Chem. Sos. 1974, 96, 5614.
23. (k) Massamune, S.; Kamata, S.; Schilling, W. J. Am. Chem. Soc. 1975, 97, 3515.
24. Takahashi, T.; Kasuga, K.; Takahashi, M.; Tsuji, J. J. Am. Chem. Soc. 1979, 101, 5072.
25. Rao, A. V. R.; Deshmukh, M. N.; Sharma, G. V. M. Tetrahedron 1987, 43, 779.
26. (n) Hitchcock, S. A.; Pattenden, G. Tetrahedron Lett. 1990, 31, 3641.
27. For selected references on other syntheses of radicicol: (o) Tichkowsky, I.; Lett, R. Tetrahedron Lett. 2002, 43, 4003.
28. For synthesis of hypothemycin: (p) Selles, P.; Lett. R. Tetrahedron Lett. 2002, 43, 4627.
29. Danishefsky, S. J.; Etheridge, S. J. J. Org. Chem. 1979, 44, 4716.
30. Danishefsky, S.; Van, C.-F.; Singh, R. K.; Gammill, R. B.; McCurry, P. M.; Fritsch, N.; Clardy, J. J. Am. Chem. Soc. 1979, 101, 7001.
31. Yamamoto, K.; Gabaccio, R. M.; Stachel, S. J.; Solit, D. B.; Chiosis, G.; Rosen, N.; Danishefsky, S. J. Angew. Chem., Int. Ed. 2003, 42, 1280.
32. (a) For an overview of Hsp90 and its emerging role in cancer treatment: Chiosis, G.; Vilenchik, M.; Kim, J.; Solit, D. Drug Discovery Today 2004, 9, 881.
33. (b) For radicicol-Hsp90 binding: Roe, S. M.; Prodromou, C.; O'Brien, R.; Ladbury, J. E.; Piper, P. W.; Pearl, C. H. J. Med. Chem. 1999, 42, 260.
34. (c) For geldanamycin-Hsp90 binding: Stebbins, C. E.; Russo, A. A.; Schneider, C.; Rosen, N.; Haiti, F. U.; Pavletich, N. P. Cell 1997, 89, 239.
35. (d) For AAG-Hsp90 binding (AAG, a derivative of geldanamycin, is the first Hsp90 inhibitor to enter clinical trials): Schulte, T. W.; Neckers, L. M. Cancer Chemother. Pharmacol. 1998, 42, 273.
36. For selected references on Hsp90 inhibitors: (e) Llauger, L.; He, H.; Kim, J.; Aguirre, J.; Rosen, N.; Peters, U.; Davies, P.; Chiosis, G. J. Med. Chem. 2005, 48, 2892.
37. (f) Chiosis, G.; Lucas, B.; Shtil, A.; Huezo, H.; Rosen, N. Bioorg. Med. Chem. 2002, 10, 3555.
38. (g) Kuduk, S. C.; Harris, C. R.; Zheng, F. F.; Sepp-Lorenzino, L.; Ouerfelli, O.; Rosen, N.; Danishefsky, S. J. Bioorg. Med. Chem. Lett. 2000, 10, 1303.
39. Garbaccio, R. M.; Stachel, S. J.; Baeschlin, D. K.; Danishefsky, S. J. J. Am. Chem. Soc. 2001, 123, 10903.
40. Yang, Z.-Q.; Danishefsky, S. J. J. Am. Chem. Soc. 2003, 125, 9602.
41. For reviews on retro Diels-Alder reactions: (a) Rickborn, B. Org. React. 1998, 52, 1.
42. (b) Ichihara, A. Synthesis 1987, 207.
43. Lasne, M.-C.; Ripoll, J.-L. Synthesis 1985, 121.
44. For examples of related retro-Diels-Alder reactions: (d) Reference 14.
45. (e) Geng, X.; Danishefsky, S. J. Org. Lett. 2004, 6, 413.
46. (f) Yang, Z.-Q.; Geng, X.; Solit, D.; Pratilas, C. A.; Rosen, N.; Danishefsky, S. J. J. Am. Chem. Soc. 2004, 126, 7881.
47. (a) Kinoshita, K.; Sasaki, T.; Awata, M.; Takada, M.; Yaginuma, S. J. Antibiot. 1997, 50, 961.
48. (b) Murakami, Y.; Ishii, A.; Mizuno, S.; Yaginuma, S.; Uehara, Y. Anticancer Res. 1999, 19, 4145.
49. (a) Musgrave, O. C. J. Chem. Soc. 1956, 4301.
50. (b) Musgrave, O. C. J. Chem. Soc. 1957, 1104.
51. (c) Birch, A. J.; Musgrave, O. C.; Richards, R. W.; Smith, H. J. Chem. Soc 1959, 3146.
52. (d) Lai, S.; Shizuri, Y.; Yamamura, S.; Kawai, K.; Terada, Y.; Furukawa, H. Tetrahedron Lett. 1989, 30, 2241.
53. (e) Ghisalberti, E. L.; Rowland, C. Y. J. Nat. Prod. 1993, 56, 2175.
54. (f) Kusano, M.; Nakagami, K.; Fujioka, S.; Kawano, T.; Shimada, A.; Kimura, Y. Biosci. Biotechnol. Biochem. 2003, 6, 1413.
55. Hanasaki, K.; Kamigaito, T.; JP 2000287697 A2 20001017 (Japanese).
56. Edrada, R. A., Heubes, M.; Brauers, G., Wray, V.; Berg, A.; Grafe, U.; Wohlfarth, M.; Muhlbacher, J.; Schaumann, K.; Sudarsono; Bringmann, G.; Proksch, P. J. Nat. Prod. 2002, 65, 1598.
57. Bringmann, G.; Lang, G.; Michel, M.; Heubes, M. Tetrahedron Lett. 2004, 45, 2829.
58. For Diels-Alder reactions with allenes: Murakami, M.; Matsuda, T. Cycloadditions of Alenes In Modern Allene Chemistry, Krause, W., Hashmi, A. S. K., Eds.; Wiley-VCH: Weinheim, 2004; Chapter 12, p 727.
59. Kozmin, S. A.; Green, M. T.; Rawal, V. H. J. Org. Chem. 1999, 64, 8045.
60. For preparation of allene 35: In a two-step process, dehydroacetic acid was unraveled to methyl 3,5-dioxohexanoate (preparation see: Solladie, G.; Colobert, F.; Denni, D. Tetrahedron: Asymmetry 1998, 9, 3081)
61. followed by treatment with freshly prepared DMC (generated from 1,3-dimethyl-2-imidazolidinone) providing allene 35 (DMC protocol: Node, M.; Fujiwara, T.; Ichihashi, S.; Nishide, K. Tetrahedron Lett. 1998, 39, 6331). For preparation of allene 42: Similarly, commercially available tert- butylacetoacetate was extended to tert-butyl 3,5-dioxohexanoate, and treatment with DMC furnished allene 42.
62. The inseparable mixture of 36/37 was selectively reduced (sodium borohydride) to give alcohol 37A and unreacted isomer 36. On the basis of its proton NMR spectroscopic pattern (the benzylic methylene protons were each a dd, and the geminal proton of alcohol was a complex multiplet), alcohol 37A was determined to arise from reduction of 37. The alcohol was oxidized (TPAP/NMO) back to ketone 37. It was then readily discernible which proton NMR peak of the Diels-Alder adducts mixture belong to which product, particularly the benzylic methylene, methyl ketone (acetyl), and methyl ester. These three distinct peaks in the NMR were subsequently used to determine the ratios of Diels-Alder products. (Equation Presented)
63. For seminal discussions on the mechanism of the Diels-Alder reaction, concerted or stepwise: (a) Woodward, R. B.; Katz, R. B. Tetrahedron 1959, 5, 70.
64. (b) Berson, J. A.; Mueller, W. A. J. Am. Chem. Soc. 1961, 83, 4947.
65. Unpublished results by T. Yoshino. For seminal work on this type of transformation: Jones, E. R. H.; Mansfield, G. H.; Whiting, M. C. J. Chem. Soc. 1954, 3208.
66. Unpublished results by T. Yoshino.
67. For halogen-metal exchange: (a) Chandrasekhar, S.; Roy, C. D. Tetrahedron 1994, 50, 8099.
68. For preparation of compound 54: (b) Stetter, H.; Steinacker, K. H. Chem. Ber. 1953, 86, 790.
69. Masamune, S.; Roush, W. R. Tetrahedron Lett. 1984, 25, 2183.
70. Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.; Dolling, U.-H.; Grabowski, J. J. Tetrahedron Lett. 1995, 36, 5461.
71. Corey, E. J.; Fuchs, P. C. Tetrahedron Lett. 1972, 3769.
72. The synthesis of diene 64 is described in Supporting Information. Cycloaddition of dienophile 62 and siloxyl diene was unsuccessful.